HUMAN EXOSKELETON SYSTEMS CONSISTING

Brand Owner (click to sort) Address Description
BERKELEY BIONICS Berkeley ExoTech, Inc. 2546 10th Street Berkeley CA 94710 human exoskeleton systems consisting of wearable supports, braces, and platforms for use in assisting human locomotion and/or lifting, carrying, and transporting loads; and body armor, namely bullet-proof vests, hard plate personal body armor clothing, and hard ballistic plate personal body armor for use with such exoskeleton systems;backpacks for use as part of a human exoskeleton system;boots; shoes; clothing, namely, pants, shirts, jackets and vests; all for use as part of a human exoskeleton system or as accessories to such system;Orthopedic braces, artificial limbs; orthotics for limbs, hands, and feet; medical, rehabilitative, therapeutic and physical therapy devices related to human injury or mobility, namely, gait trainers;BIONICS;
ELEGS Berkeley ExoTech, Inc. 2546 10th Street Berkeley CA 94710 human exoskeleton systems consisting of wearable supports, braces, and platforms for use in assisting human locomotion and/or lifting, carrying, and transporting loads;backpacks;boots; shoes; clothing, namely, pants, shirts, jackets and vests;E LEGS; EXOSKELETON LEGS;orthopedic braces; orthotics for limbs, hands, and feet; medical, rehabilitative, therapeutic and physical therapy devices related to human injury or mobility, namely, gait trainers;
ILEGS Berkeley ExoTech, Inc. 2546 10th Street Berkeley CA 94710 human exoskeleton systems consisting of wearable supports, braces, and platforms for use in assisting human locomotion and/or lifting, carrying, and transporting loads; Orthopedic braces, artificial limbs; orthotics for limbs, hands, and feet; medical, rehabilitative, therapeutic and physical therapy devices related to human injury or mobility, namely, gait trainers; backpacks; boots; shoes; clothing, namely, pants, shirts, jackets and vests;I LEGS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Described are conjugates formed by an antibody fragment covalently attached to a non-proteinaceous polymer, wherein the apparent size of the conjugate is at least about 500 kD. The conjugates exhibit substantially improved half-life, mean residence time, and/or clearance rate in circulation as compared to the underivatized parental antibody fragment. Also described are conjugates directed against human vascular endothelial growth factor (VEGF), human p185 receptor-like tyrosine kinase (HER2), human CD20, human CD18, human CD11a, human IgE, human apoptosis receptor-2 (Apo-2), human tumor necrosis factor-? (TNF-?), human tissue factor (TF), human ?4?7 integrin, human GPIIb-IIIa integrin, human epidermal growth factor receptor (EGFR), human CD3, and human interleukin-2 receptor ?-chain (TAC) for diagnostic and therapeutic applications.